We attempted to identify the Mycobacterium avium complex (MAC) isolated in Japan by using DNA probes specific for M. avium or Mycobacterium intracellulare (Gen-Probe Rapid Diagnostic System for MAC; Gen-Probe, Inc., San Diego, Calif.). The source and drug susceptibility distributions were examined. This assay system proved to be rapid, sensitive, specific, and reliable for identification of MAC and of the species as either M. avium or M. intracellulare. The DNA probe test showed that of the generally accepted MAC serovars, serovars 1 to 6, 8 to 11, and 21 belonged to M. avium and 7 and 12 to 20 belonged to M. intracellulare. Moreover, with the DNA probe test we found that the distribution patterns of M. avium and M. intracellulare isolates in Japan differed depending on the district in which MAC was isolated. The ratio of M. avium was much higher in eastern Japan. In Tokai and Shimane districts, the ratio of M. avium and M. intracellulare isolates significant in human disease was related to that of isolates from soil and house dust (natural sources). In M. avium, human disease-associated isolates were more resistant to rifampin, streptomycin, and kanamycin than were isolates from natural sources. However, this source dependence was not evident for M. intracellulare. In human disease-associated MAC, M. avium isolates were more resistant to most agents, except for quinolones, than were M. intracellulare isolates.
Mycobacterium avium and Mycobacterium intracellulare are virtually indistinguishable phenotypically and are referred to as the M. aviuim complex (MAC). Conventional culture and biochemical tests do not provide a clear differentiation between the two. The known biochemical differences between the two species lie in the activities of arylsulfatase and nitrite reduction (11) . However, it is difficult to differentiate M. avium and M. intracellulare on the basis of enzyme activities because the features are not always consistent.
DNA probe technology facilitates a rapid and specific identification of microorganisms. A commercial kit (GenProbe Rapid Diagnostic System for MAC; Gen-Probe, Inc., San Diego, Calif.) is available for confirmation and identification of species of organisms belonging to MAC (4) . This system is based on the hybridization of 1251-labeled DNA probes for M. avium and for M. intracellulare with rRNA from a test organism. Using the DNA probe test, we attempted to identify MAC freshly isolated in Japan. The source and drug susceptibility distributions of MAC isolates were examined. MATERIALS a-Antigen analysis. a-Antigen of test mycobacteria was analyzed by agar gel precipitation with anti-cx-antigen serum, as described elsewhere (10) .
Drug susceptibility testing. MICs of rifampin, rifabutin, lamprene, streptomycin, kanamycin, ethambutol, ofloxacin, and ciprofloxacin against MAC were determined by the usual agar dilution method with Middlebrook 7H11 medium, as described previously (8) . DNA probes, respectively. Conversely, another MAC strain belonging to serovar 7 gave percent hybridization values of 1.4 and 42.2% in response to M. avium and M. intracellulare DNA probes, respectively. Results of the DNA probe test clearly identified MAC strains belonging to serovars 1 to 21. With DNA probe testing, MAC belonging to serovars i to 6, 8 to 11, and 21 was identified as M. avium and MAC belonging to serovars 7, 12 to 20, and 25 was identified as M. intracellulare (9; manuscript in preparation). In the latter part of this work, we attempted to identify MAC strains isolated from vqrious sources, such as humans, swine, and the environment in Japan.
RESULTS

Comparison
Distribution of M. avium and M. intracellulare isolated in various areas of Japan. Figure 1 and Table 1 show the distribution of M. avium and M. intracellulare significant in human disease and isolated in various districts of Japan. Two hundred thirty-one MAC strains isolated mainly at 13 national sanatoriums were tested for their reactivity with M. avium and M. intracellulare probes. In Hokkaido, Kanto, Table 2 shows the distribution of M. avium and M. intracellulare isolates from humans and from natural sources (soil, house dust, and water) in Tokai and Shimane districts. In Tokai District, disease-associated MAC had a higher ratio of M. avium (56%) than of M. intracellulare (44%). It is noteworthy that in this district, the ratio of M. av'ium isolates from natural sources (80%) was also higher than that of M. intracellulare (20%) ( Table 2 ). Therefore, there may be some correlation between the distribution of M. aviuin and M. intracellulare isolates of human origin and that of isolates from natural sources, at least in Tokai District, as discussed below. In Shimane District, although the number of test isolates was too small for a conclusion to be reached, the ratio of M. avium isolates was lower than that of M. intracellulare isolates from both human and natural sources.
Growth of MAC strains at 45°C. Table 3 shows the growth at 45°C of M. avium and M. intracellulare isolated from various sources. In the case of M. avium, many isolates from humans and all the isolates from swine grew at that temperature. All the M. avi'um isolates from pigpen sawdust also grew at 45°C, implying contamination of sawdust with M. avium of swine origin. On the other hand, all the M. a'ium isolates from house dust and soil did not grow at 45°C. The ratio of 45°C growth-positive isolates from humans was significantly different from that of natural source-derived isolates (P < 0.01, x2 test). All the test strains of M. intracellulare were negative for growth at 45°C, regardless of their origin.
Susceptibilities of MAC strains to various antimicrobial agents. Table 4 lists the susceptibilities of human diseaseassociated and natural source-derived M. av'iuin and M.
intracellulare isolates identified by the DNA probe test to various antimicrobial agents. Human disease-associated isolates of M. aviium were more resistant to rifampin, streptomycin, and kanamycin than were M. aviulm isolates from natural sources. However, irrespective of the source, M.
intracellulare was equally susceptible to all the test agents.
In the case of human-derived MAC, M. av'ium was fourfold more resistant to rifampin than was M. intracellidare. 11 , and 21 showed positive hybridization with M. avium probe but not with M. intracellulare probe, indicating that these serovars belong to M. av'ium. In contrast, MAC strains of serovars 7, 12 to 20, and 25 showed positive hybridization with M. intracellulare probe but not with M. avium probe, indicating that these serovars are M. intracellulare (9; manuscript in preparation). This is in agreement with the results of DNA-DNA hybridization tests by Baess (1, 2) and sensitin tests on guinea pigs by Magnusson (6) , which suggested that strains belonging to serovars 4 to 6 and 8 were more closely related to M. avium than to M. intracellulare. However, complicated results were obtained for the remaining serovars; i.e., most organisms belonging to these serovars were reactive neither to M. a'izun nor to M. intracellulare probe, although the organisms of serovars 23 and 28 had MAC-specific a-antigen. Moreover, the organisms of serovars 22 and 27 had ai-antigen specific for M. scrofulaceum (9; manuscript in preparation).
MAC strains with a-antigen specific for MAC did not always give a clear-cut value for positive hybridization with either M. aviiin or M. intracellulare probe. Two of 231 MAC strains isolated from patients showed low percent hybridization values to M. aviun and M. intracellulare probes (strain N-294, 7.7 to 17.3 and 2.6 to 9.3% for M. avium probe and M. intracellulare probe, respectively; strain N-297, 1.1 and 1.1%, respectively). Thus, it is difficult or impossible to be certain that these are MAC strains. However, both strains possessed MAC-specific cs-antigen. Similar exceptions have been described by Enns (4) . He reported that 8 of 60 strains identified as MAC by conventional culture and biochemical identification had no positive hybridization values (.10%) with either the M. aviuîn or M. intracellulare probe and that 1 in 53 strains identified as MAC by the DNA probe test was a mycobacterium other than MAC, as determined by conventional culture and biochemical tests. Therefore, it is important to develop additional DNA probes which can cover or eliminate these exceptional strains.
As for the results presented in Table 2 , the x2 test indicated a statistically significant difference (P < 0.05) intracellulare. The difference between this ratio and that for human disease isolates was significant (P < 0.01), indicating the close epidemiologic relation of disease-associated MAC with house-dust-derived MAC but not with soil-derived MAC. The DNA probe test for MAC described in this article is most useful for identifying MAC strains at the species level. Using this system, we elucidated the precise distribution of M. avium and M. intracellulare in various districts of Japan ( Fig. 1 and Table 1 ). It is interesting to note that M. avium and M. intracellulare are distributed predominately in the eastern and western parts of Japan, respectively. Because there is no marked difference between the two regions in such epidemiologic factors as population, race, age, sanitary conditions, mode of life, and climate (the eastern region is somewhat colder than the western), further studies of other epidemiologic factors are required.
